Back to all News

Development of a novel assay for direct assessment of selective amylin receptor activation reveals novel differences in behaviour of selective and non-selective peptide agonists.

Keov P, Christopoulos G, Hick CA, Glendorf T, Ballarín-González B, Wootten D, Sexton PM (2024). Mol Pharmacol 105(5): 359-373.  with industry partner Novo Nordisk DOI: https://doi.org/10.1124/molpharm.123.000865